GlaxoSmithKline PharmaceuticalsGLAXO 
$33.741.82%24h
1.82%24h
Global rank2498
Market cap$5.72B
Change 7d0.61%
YTD Performance48.60%
SP500 benchmarkOutperform
P/E0.94
P/S14.75
Revenue$387.36M
Earnings$72.75M
Dividend yield-
Main Sector
Healthcare
Category
GlaxoSmithKline Pharmaceuticals (GLAXO) Total Liabilities
GLAXO Total Liabilities in 2022: $188.85M
According to GlaxoSmithKline Pharmaceuticals latest financial reports the total liabilities of GLAXO is $188.85M, an decrease of -19.54% to 2022. At the end of 2022 company had $234.71M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that GlaxoSmithKline Pharmaceuticals is responsible for during its operational activities.
GlaxoSmithKline Pharmaceuticals (GLAXO) Total Liabilities History from 2023 to 2022
-
Value:-
GLAXO Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $188.85M | -19.54% |
| 2022 | $234.71M | 20.41% |
| 2021 | $194.93M | 24.45% |
| 2020 | $156.64M | 210.37% |
| 2019 | $50.47M | - |
View the Top Total Liabilies Stocks
